News & Updates

NSAID use ups risk of heart failure in T2DM patients
NSAID use ups risk of heart failure in T2DM patients
17 Apr 2023

Use of nonsteroidal anti-inflammatory drugs (NSAIDs) tends to elevate the risk of first-time hospitalization for heart failure (HF) in patients with type 2 diabetes mellitus (T2DM), a study has shown. In addition, those with advanced age, elevated haemoglobin (Hb) A1c levels, and new users are particularly at higher risk.

NSAID use ups risk of heart failure in T2DM patients
17 Apr 2023
Preop hypertension, hypercholesterolemia foretell T2DM persistence after metabolic surgery
Preop hypertension, hypercholesterolemia foretell T2DM persistence after metabolic surgery
09 Apr 2023

For patients with obesity and type 2 diabetes mellitus (T2DM) who are scheduled to undergo metabolic surgery, the presence of hypertension and hypercholesterolemia at baseline may predict failure of T2DM remission after the procedure, according to a study.

Preop hypertension, hypercholesterolemia foretell T2DM persistence after metabolic surgery
09 Apr 2023
Obesity may induce RAAS activation in children
Obesity may induce RAAS activation in children
04 Apr 2023

Obesity appears to play a major role in the activation of the renin‒angiotensin‒aldosterone system (RAAS), with a noticeable rise of angiotensin-converting enzyme (ACE) and ACE activities during childhood, reveals a recent study. In addition, sex differences are present in the association of ACE and ACE2 activities with blood pressure (BP).

Obesity may induce RAAS activation in children
04 Apr 2023